We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LVTX market cap is 46.27M. The company's latest EPS is USD -1.5966 and P/E is -1.11.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.14M | 53k | 353k | 6.99M | 0 |
| Operating Income | -13.55M | -18.31M | -15.89M | -1.95M | -9.36M |
| Net Income | -12.7M | -8.84M | -6.5M | -553k | -8.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 3.5M | 5.35M | 19.39M | 6.77M |
| Operating Income | -9.58M | -14.92M | -43.61M | -34.84M | -43.25M |
| Net Income | -9.69M | -15.51M | -42.36M | -31.91M | -41.97M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 122.54M | 111.02M | 101.71M | 99.08M | 92.28M |
| Total Liabilities | 58.65M | 56.42M | 50.53M | 48.41M | 49.41M |
| Total Equity | 63.89M | 54.6M | 51.18M | 50.67M | 42.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.8M | 20.49M | 139.25M | 143.43M | 101.71M |
| Total Liabilities | 2.95M | 12.87M | 20.88M | 57.39M | 50.53M |
| Total Equity | 5.84M | 7.62M | 118.37M | 86.04M | 51.18M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.4M | -28.85M | -38.97M | -1.13M | -9.51M |
| Investing | 7.9M | -8.95M | -17.64M | 718k | 1.06M |
| Financing | -254k | -391k | -571k | N/A | 5k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.62M | -9.31M | -28.65M | 4.04M | -38.97M |
| Investing | -792k | -502k | -43.55M | 9.35M | -17.64M |
| Financing | 1.18M | 18.97M | 151.16M | 283k | -571k |
| Market Cap | 46.27M |
| Price to Earnings Ratio | -1.11 |
| Price to Sales Ratio | 6.87 |
| Price to Cash Ratio | 1.05 |
| Price to Book Ratio | 0.91 |
| Dividend Yield | - |
| Shares Outstanding | 26.29M |
| Average Volume (1 week) | 27.94k |
| Average Volume (1 Month) | 69.1k |
| 52 Week Change | 18.92% |
| 52 Week High | 6.47 |
| 52 Week Low | 1.35 |
| Spread (Intraday) | 0.01 (0.56%) |
| Company Name | LAVA Therapeutics NV |
| Address |
yalelaan 62 utrecht, utrecht 3584 CM |
| Website | https://www.lavatherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
